Li Xiaohong, Ji Xiongfa, Chen Kun, Ullah Muhammad Wajid, Li Basen, Cao Jiameng, Xiao Lin, Xiao Jun, Yang Guang
Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
Department of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
Bioact Mater. 2021 Jan 12;6(7):2105-2119. doi: 10.1016/j.bioactmat.2020.12.013. eCollection 2021 Jul.
-catheter arterial embolization (TAE) plays an important role in treating various diseases. The available embolic agents lack X-ray visibility and do not prevent the reflux phenomenon, thus hindering their application for TAE therapy. Herein, we aim to develop a multifunctional embolic agent that combines the X-ray radiopacity with local procoagulant activity. The barium sulfate nanoparticles (BaSO NPs) were synthesized and loaded into the polyvinyl alcohol/chitosan (PVA/CS) to prepare the radiopaque BaSO/PVA/CS microspheres (MS). Thereafter, thrombin was immobilized onto the BaSO/PVA/CS MS to obtain the thrombin@BaSO/PVA/CS MS. The prepared BaSO/PVA/CS MS were highly spherical with diameters ranging from 100 to 300 μm. CT imaging showed increased X-ray visibility of BaSO/PVA/CS MS with the increased content of BaSO NPs in the PVA/CS MS. The biocompatibility assessments demonstrated that the MS were non-cytotoxic and possessed permissible hemolysis rate. The biofunctionalized thrombin@BaSO/PVA/CS MS showed improved hemostatic capacity and facilitated hemostasis . Additionally, study performed on a rabbit ear embolization model confirmed the excellent X-ray radiopaque stability of the BaSO/PVA/CS MS. Moreover, both the BaSO/PVA/CS and thrombin@BaSO/PVA/CS MS achieved superior embolization effects with progressive ischemic necrosis on the ear tissue and induced prominent ultrastructural changes in the endothelial cells. The findings of this study suggest that the developed MS could act as a radiopaque and hemostatic embolic agent to improve the embolization efficiency.
经导管动脉栓塞术(TAE)在治疗各种疾病中发挥着重要作用。现有的栓塞剂缺乏X射线可视性,且不能防止反流现象,从而阻碍了它们在TAE治疗中的应用。在此,我们旨在开发一种兼具X射线不透射性和局部促凝血活性的多功能栓塞剂。合成了硫酸钡纳米颗粒(BaSO NPs)并将其负载到聚乙烯醇/壳聚糖(PVA/CS)中,制备出具有不透射X射线特性的BaSO/PVA/CS微球(MS)。此后,将凝血酶固定在BaSO/PVA/CS MS上,得到凝血酶@BaSO/PVA/CS MS。制备的BaSO/PVA/CS MS呈高度球形,直径范围为100至300μm。CT成像显示,随着PVA/CS MS中BaSO NPs含量的增加,BaSO/PVA/CS MS的X射线可视性增强。生物相容性评估表明,这些微球无细胞毒性且溶血率在允许范围内。生物功能化的凝血酶@BaSO/PVA/CS MS显示出改善的止血能力并促进了止血。此外,在兔耳栓塞模型上进行的研究证实了BaSO/PVA/CS MS具有出色的X射线不透射稳定性。而且,BaSO/PVA/CS和凝血酶@BaSO/PVA/CS MS均实现了卓越的栓塞效果,使耳部组织出现进行性缺血坏死,并在内皮细胞中诱导了明显的超微结构变化。本研究结果表明,所开发的微球可作为一种不透射X射线且具有止血作用的栓塞剂,以提高栓塞效率。